Bionano teams with Nvidia to develop acceleration platform

Bionano Genomics (BNGO) announced a collaboration with NVIDIA (NVDA) to develop an acceleration platform for use in Bionano’s optical genome mapping, OGM,workflow. This collaboration is expected to significantly improve data processing speed while reducing time and cost associated with secondary analysis of OGM data. The computation platform is designed to enable a small laboratory and information technology footprint, which would allow for rapid decentralized deployment. By combining NVIDIA’s expertise in accelerated computing and the capabilities of the NVIDIA RTX 6000 Ada Generation professional GPU with Bionano’s knowledge in extraction, enzymatic treatment, and analysis of ultra-high molecular weight DNA molecules, the collaboration aims to develop on-premise and cloud-based solutions to keep pace with the anticipated data generation needs of high-throughput OGM workflows. The collaborative solution is projected to support analysis of 96 cancer workflows or just over 300 constitutional whole genomes per week and be integrated with Bionano’s NxClinical(TM) software for variant interpretation and reporting. Bionano will preview the solution with NVIDIA at the Advances in Genome Biology and Technology General Meeting, which will take place February 6-9, 2023, in Hollywood, Florida.